Antisense oligonucleotides directed against connective tissue growth factor and uses thereof

Details for Australian Patent Application No. 2010224447 (hide)

Owner Isis Pharmaceuticals, Inc. Excaliard Pharmaceuticals, Inc.

Inventors Bennett, C. Frank; Foulkes, J. Gordon; O'Donnell, Niall; Dean, Nicholas M.; Frier, Susan M.

Agent FB Rice

Pub. Number AU-A-2010224447

Parent 2009275387

Filing date 28 September 2010

Wipo publication date 21 October 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

14 October 2010 Complete Application Filed

21 October 2010 Application Open to Public Inspection

  Published as AU-A-2010224447

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010224448-Trolleys

2010224446-Access hatch for pump station